Latest dealsDeals See all deals→
Health

The 7 Questions to Ask Before Choosing a Peptide Therapy Clinic

The 7 Questions to Ask Before Choosing a Peptide Therapy Clinic
The 7 Questions to Ask Before Choosing a Peptide Therapy Clinic


Peptide therapy has moved from a niche medical offering into something you can find at nearly any med spa, telehealth platform, or wellness clinic. That is good news in terms of access. It is also a problem.

The therapy itself works well when it is done well. But the quality of peptide therapy delivery varies enormously, from supervised naturopathic medical practice at one end to online-only prescription mills at the other. The peptide is often the same across the spectrum. The outcomes are not.

If you are considering peptide therapy whether for weight loss, recovery, hormone support, or anti-aging the questions you ask before starting matter more than most patients realize. The right questions filter out the shallow providers quickly, and they tell you a lot about what kind of care you will actually receive.

Here are the seven questions worth asking at any peptide therapy consultation, and what the right answers look like.

 

1. Is this peptide FDA-approved, or is it being compounded?

This matters because it tells you about the regulatory and supply chain context of your treatment. FDA-approved peptides like Semaglutide (Wegovy) and Tirzepatide (Zepbound) have gone through formal clinical trials and are regulated to standardized quality. Compounded peptides can be legitimate too, but they come from compounding pharmacies with varying quality controls.

Neither path is inherently wrong. But a provider who cannot tell you clearly which category their peptide falls into is a provider who hasn't thought carefully enough about what they are prescribing. The honest answer is specific: "This is Semaglutide, FDA-approved under Wegovy" or "This is a compounded formulation of BPC-157 from [specific pharmacy], and here is why we use this source."

 

2. Will you run baseline labs before prescribing?

A proper peptide protocol starts with labs. Not necessarily a full workup for every peptide, but enough to confirm the therapy is appropriate for your biology. For GLP-1 weight loss peptides, baseline labs typically include thyroid function, metabolic markers, kidney and liver function, and a thorough medical history. For recovery peptides, labs may be less extensive but still include inflammation markers and baseline health confirmation.

A provider who writes a prescription without any labs is a provider operating on symptoms alone. That is not peptide therapy. That is a prescription mill.

 

3. Who exactly will be prescribing and monitoring?

In naturopathic and integrative practices, the prescribing provider is typically a licensed medical doctor, naturopathic doctor, or nurse practitioner. In some telehealth models, you may be prescribed by a provider you never actually meet, who reviews your intake form and signs off within minutes.

Both are legal. Only one is clinical. Ask who will actually see your labs when they come back, who will adjust your dose if side effects appear, and who you call if you have a question in week 3. If the answer is unclear, you are looking at a prescription service, not a medical practice.

 

4. How will you adjust the protocol if I am not responding well?

Peptide protocols should not be set-and-forget. Doses need to be titrated. Side effects need to be managed. Some patients respond quickly; others need more time or a different approach. The provider should be able to tell you specifically how they handle adjustment, what triggers it, how often follow-ups happen, and what the decision framework is.

"We just increase the dose at the standard schedule" is not an answer. The right answer sounds like: "At your 4-week check, we review how you are tolerating it, assess early response, and adjust accordingly. If you are not responding by week 8, we rework the plan or consider underlying factors."

 

5. What underlying conditions might affect this therapy?

Weight loss peptides work differently in patients with hypothyroidism, insulin resistance, hormone imbalances, or chronic inflammation. Recovery peptides work differently in patients with poor sleep, high stress, or inadequate nutrition. A good provider addresses these upfront, not after the therapy stalls.

The question "What underlying conditions might affect this?" is a filter. A thoughtful provider will walk you through what they look for and why. A shallow one will say "it works for most people" and move on. The second answer tells you they are not prepared to help if you are not one of the "most people."

 

6. What is the follow-up and lab review cadence?

For peptide therapy to produce durable results, there needs to be a monitoring plan. For weight loss peptides, typical cadence is lab review at 8 and 16 weeks, with symptom check-ins between. For recovery peptides, progress review at 4 and 8 weeks. For hormone-adjacent peptides, labs may be more frequent.

If a provider cannot tell you their follow-up schedule in specifics, there is no plan. If the answer is "come back when you are out of medication," that is a prescription schedule, not a care plan.

 

7. What is the plan when the protocol ends?

This is the question most patients forget to ask, and the one that most predicts long-term results. GLP-1 weight loss peptides, for example, often produce weight gain if the therapy is stopped abruptly without a tapering and maintenance plan. Recovery peptides may require periodic re-cycling for ongoing issues.

A good provider has thought about what happens on day 90 of your protocol. They will tell you about tapering, maintenance, lifestyle integration, and what to watch for. A provider who has no answer here is a provider who treats peptide therapy as a transaction, not a longitudinal care relationship.

 

Red flags to watch for

A few patterns worth avoiding in any peptide therapy clinic:

  • "Subscription" pricing models with no clinical review
  • Prescription written in the first consultation without any lab work
  • No in-person visit requirement, even for first evaluation
  • Vague answers to any of the seven questions above
  • Marketing that overpromises specific outcomes
  • Compounded peptides without clear source transparency

Any one of these alone may not be disqualifying. Several together usually are.

 

Closing

Peptide therapy, done well, is a legitimate and increasingly well-studied clinical tool. Done poorly, it is a prescription convenience with questionable outcomes. The difference between the two shows up before you ever receive your first injection  in how the clinic answers these questions.

Ask them. The answers will tell you most of what you need to know.